FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition

Chenjie Xu, Zhenglong Yuan, Nathan Kohler, Jaemin Kim, Maureen A. Chung, Shouheng Sun

Research output: Contribution to journalArticlepeer-review


Chemically disordered face centered cubic (fcc) FePt nanoparticles (NPs) show the controlled release of Fe in low pH solution. The released Fe catalyzes H2O2 decomposition into reactive oxygen species within cells, causing fast oxidation and deterioration of cellular membranes. Functionalized with luteinizing hormone-releasing hormone (LHRH) peptide via phospholipid, the fcc-FePt NPs can bind preferentially to the human ovarian cancer cell line (A2780) that overexpresses LHRH receptors and exhibit high toxicity to these tumor cells. In contrast, the fcc-FePt NPs pre-etched in the low pH (4.8) buffer solution show nonappreciable cytotoxicity. The work demonstrates that fcc-FePt NPs may function as a new type of agent for controlled cancer therapy.

Original languageEnglish (US)
Pages (from-to)15346-15351
Number of pages6
JournalJournal of the American Chemical Society
Issue number42
StatePublished - Oct 28 2009
Externally publishedYes

ASJC Scopus subject areas

  • Catalysis
  • Chemistry(all)
  • Biochemistry
  • Colloid and Surface Chemistry


Dive into the research topics of 'FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition'. Together they form a unique fingerprint.

Cite this